Quick Answer
VOLITIONRX LTD reported Long Term Debt of $5.82 million for the year ending 2025.
- VOLITIONRX LTD showed an increase of +47.2% in Long Term Debt from 2024 to 2025.
- This data is from VOLITIONRX LTD's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $691.9 thousand | Q2 2017: $1.06 million | Q3 2017: $1.05 million | Q1 2018: $1.30 million | Q2 2018: $1.98 million | Q3 2018: $1.87 million | Q4 2018: $3.02 million | Q1 2019: $1.80 million | Q2 2019: $3.00 million | Q2 2019: $1.96 million | Q3 2019: $1.73 million | Q1 2020: $2.06 million | Q2 2020: $1.91 million | Q3 2020: $1.83 million | Q1 2021: $2.39 million | Q2 2021: $2.22 million | Q3 2021: $2.03 million | Q1 2022: $2.03 million | Q2 2022: $1.74 million | Q3 2022: $2.28 million | Q1 2023: $2.55 million | Q2 2023: $2.45 million | Q3 2023: $2.09 million | Q1 2024: $3.37 million | Q2 2024: $3.87 million | Q3 2024: $3.84 million | Q1 2025: $5.53 million | Q2 2025: $5.77 million | Q3 2025: $5.57 million.
- Over the full 10 years of available data (2016 to 2025), VOLITIONRX LTD's Long Term Debt has grown by 1,246.8%.
- Historical annual values: Fiscal year 2025: $5.82 million | Fiscal year 2024: $3.95 million | Fiscal year 2023: $3.62 million | Fiscal year 2022: $2.78 million | Fiscal year 2021: $2.27 million | Fiscal year 2020: $2.61 million | Fiscal year 2019: $2.20 million | Fiscal year 2018: $1.98 million | Fiscal year 2017: $1.31 million | Fiscal year 2016: $432.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: